Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)

Chandra Belani, Frank Fossella

Research output: Contribution to journalArticlepeer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)'. Together they form a unique fingerprint.

Medicine & Life Sciences